1-phenyl-2-decanoylamino-3-morpholino-1-propanol has been researched along with alpha-synuclein in 1 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Fujita, M; Hashimoto, M; Masliah, E; Nakai, M; Sekigawa, A; Sugama, S; Takenouchi, T; Waragai, M; Wei, J | 1 |
1 other study(ies) available for 1-phenyl-2-decanoylamino-3-morpholino-1-propanol and alpha-synuclein
| Article | Year |
|---|---|
Protective role of endogenous gangliosides for lysosomal pathology in a cellular model of synucleinopathies.
Topics: alpha-Synuclein; Animals; Apoptosis; Autophagy; beta-Synuclein; Cell Membrane Permeability; Cells, Cultured; Enzyme Inhibitors; Fluorescent Antibody Technique; Gangliosides; Glucosyltransferases; Immunoblotting; Inclusion Bodies; Lysosomal-Associated Membrane Protein 2; Lysosomes; Morpholines; Neuroblastoma; Neurodegenerative Diseases; Rats; Reverse Transcriptase Polymerase Chain Reaction; RNA, Messenger | 2009 |